Cárdenas SCM, Gutiérrez SJE, Márquez EC, Sánchez MFP, Gallardo PGJ, Eljure EM

Language: Spanish
References: 19
Page: 168-178
PDF size: 394.97 Kb.

ABSTRACT

Almost every surgical patient has enough risk factors to develop venous thromboembolic disease. Therefore, a review of the medical literature was needed to answer the following questions: when, how and why is thromboprophylaxis needed in plastic surgery? After thorough research we concluded that Caprini’s 2005 scale was the best for thromboembolic risk stratification in plastic surgery patients. A flow chart was then devised to determine the prophylactic therapy needed. The medications, dosages, duration of treatment and instructions are specified. Evidence suggests that 40 mg of enoxaparin administered subcutaneously every 24 hours in patients in need, according to their risk score, are adequate. The contraindications of the wide array of prophylactic treatments are explained, and lastly we concluded that enoxaparin used as shown in the guidelines does not increase the risk of a major bleeding event requiring an additional surgery.

REFERENCES

1. Seruya M, Baker SB. Venous thromboembolism prophylaxis in plastic surgery patients. Plast Reconstr Surg. 2008; 122 (3 Suppl): 1-9.

2. Miszkiewicz K, Perreault I, Landes G et al. Venous thromboembolism in plastic surgery: incidence, current practice and recommendations. J Plast Reconstr Aesthet Surg. 2009; 62 (5): 580-588.

3. Broughton G, Rios JL, Rohrich RJ et al. Deep venous thrombosis prophylaxis practice and treatment strategies among plastic surgeons: survey results. Plast Reconstr Surg. 2007; 119 (1): 157-174.

4. Clavijo JA, Rubin JP. Approach to venous thromboembolism prophylaxis: are we evolving fast enough in plastic surgery? Ann Plast Surg. 2011; 66 (3): 306-309.

5. Enajat M, Damen TH, Geenen A et al. Pulmonary embolism, after abdominal flap breast reconstruction: prediction and prevention. Plast Reconstr Surg. 2013; 131 (6): 1213-1222.

6. Hatef DA, Kenkel JM, Nguyen MQ et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008; 122 (1): 269-279.

7. Pannucci CJ, Bailey SH, Dreszer G et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011; 212 (1): 105-112.

8. Poore SO, Sillah NM, Mahajan AY et al. Patient safety in the operating room: II. Intraoperative and postoperative. Plast Reconstr Surg. 2012; 130 (5): 1048-1058.

9. Murphy RX Jr, Alderman A, Gutowski K et al. Evidence based practices for thromboembolism prevention: summary of the ASPS venous thromboembolism task force report. Plast Reconstr Surg. 2012; 130 (1): 168e-175e.

10. Gould MK, Garcia DA, Wren SM et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic therapy and prevention of thrombosis, 9th Ed: American college of chest physicians’ evidence based clinical practice guidelines. Chest. 2012; 141 (2 Suppl): 2227S-77S.

11. Young VL, Watson ME. The need for venous thromboembolism (VTE) prophylaxis in plastic surgery. Aesthet Surg J. 2006; 26 (2): 157-175.

12. Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest. 2003; 124 (6 Suppl): 379S-385S.

13. Pannucci CJ, Dreszer G, Wachtman CF et al. Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg. 2011; 128 (5): 1093-1103.

14. Keith JN, Chong TW, Davar D et al. The timing of preoperative prophylactic low-molecular-weight heparin administration in breast reconstruction. Plast Reconstr Surg. 2013; 132 (2): 279-284.

15. Pannucci CJ, Wachtman CF, Dreszer G et al. The effect of postoperative enoxaparin on risk for reoperative hematoma. Plast Reconstr Surg. 2012; 129 (1): 160-168.

16. Dini GM, Ferreira MC, Albuquerque LG et al. How safe is thromboprophylaxis in abdominoplasty? Plast Reconstr Surg. 2012; 130 (6): 851e-857e.

17. Pontelli PE, Scialom MJ et al. Pharmacologic and intermittent pneumatic compression thromboembolic prophylaxis in 563 consecutive abdominoplasty cases. Rev Bras Cir Plast. 2012; 27 (1): 77-86.

18. Seruya M, Venturi ML, Iorio ML et al. Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients. Plast Reconstr Surg. 2008; 122 (6): 1701-1708.

19. Pannucci CJ, Jaber RM, Zumsteg JM et al. Changing practice: implementation of a venous thromboembolism prophylaxis protocol at an academic medical center. Plast Reconstr Surg. 2011; 128 (5): 1085-1092.